SC144 did significantly reverse M-BMDM-promoted tumor growth with no observed inhibitory effects for LLC alone group (Fig. 1K, L; Fig. S7C), indicating that early SC144 treatment suppresses tumor growth mainly by interfering with IL-6/gp130/STAT3 cascade in M2 macrophages, but not in tumor cells. This evidence concerns the gene IL6 and neoplasm.